Interview with Inés Ruedas, winner of the Syva Award 2023 – Tierras Porcino
We could not miss this excellent interview, conducted by Interempresas for Tierras Porcino, which recently interviewed our Syva 2022 award winner, Inés Ruedas Torres, about her thesis and the numerous challenges that the pig sector faces in the fight against PRRSV.
In her interview, Inés speaks about the new advances in the fight against this disease, but also about the many unknowns that remain to be elucidated about the immunopathogenesis of the virus and its different strains, and about the paths that still need to be investigated in order to achieve this.
Indeed, 40 years after its emergence, this virus is still one of the pathogens with the greatest economic impact in the pig sector, due to the absence of fully effective control tools. In addition to affecting the reproductive tract of breeding sows and the respiratory system of young animals, it is often associated with other secondary diseases. PRRSV is also characterised by the wide diversity of clinical signs it causes in infected animals. The disease can range from asymptomatic or subclinical to severe reproductive and respiratory disease. Depending on the strain and its virulence, on-farm mortality can reach 100%.
to know more about the importance not only of her thesis, but also of the work that has motivated the research of the UCO-PIG team that has endorsed Inés for many years, we invite you to read the interview with Inés.
Click here to read the interview. In Spanish Original article
Click here to read the article translated in english
In the opinion of the jury that voted it the best thesis in animal health of the 26th edition of the Syva Prize, the thesis of Inés Ruedas represents a fundamental advance in the knowledge of the pathogenesis of porcine reproductive and respiratory syndrome virus (PRRSV) and a reference for future studies. It is this type of thesis and research that Syva wishes to promote and highlight in each edition of the Syva Prize.
When we asked Inés how winning the Syva award, undoubtedly the most valued animal health prize in the Spanish scientific community, has changed her life, she replied: “Winning the Syva award has been a truly transformative experience at all levels of my life”. … Inés also highlights the incredible emotional boost of winning this prize, the great confidence in her abilities and potential as a researcher, but also the doors that have opened professionally, the impact on her visibility in the world and the interest generated by her work and that of the team that has accompanied her, which includes Librado Carrasco (thesis tutor), Jaime Gómez Laguna (thesis supervisor), and Irene Rodríguez Gómez (thesis supervisor).
There is no doubt that Inés, like the winners of previous editions, but also Daniel Rodríguez Martín and María Canive Ruiz, the other two winners of this 2022 edition, as well as the research groups that endorse them, are the ambassadors of the spirit of the Syva Prize and the driving force behind its notoriety beyond Spain’s borders, its longevity and its continuity over time. For this, thank you all!
You may also be interested in
30 January, 2025
Syvac® EH Marker, the first and only DIVA vaccine against EHD, is now authorized in Belgium
Syva is pleased to announce that the FAMHP/FAGG has granted emergency use authorization for its marker (DIVA) vaccine against EHD in accordance with Article 110(2) of Regulation (EU) 2019/6 for use in cattle and deer.
24 January, 2025
Call for the 28th edition of the Syva Award International for the best doctoral thesis in Animal Health
We are pleased to remind you that the call for applications for the 28th Syva Award International is open until 18 February 2025. We also remind you that for two years now, the Syva Award International is no longer limited to Spanish candidates, but invites all doctoral students of any nationality who have submitted their thesis in animal health...
22 January, 2025
Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).
On 15 January 2025, the Committee for Medicinal Products for Veterinary Use (CVMP) issued a positive opinion recommending the granting of a marketing authorization for Syvazul BTV 3 vaccine. This step forward marks an important milestone in the fight against Bluetongue, and Syva is proud to be at the forefront of this innovation.
Media tool kit
We provide users, particularly journalists and the press, with a series of graphic documents, photographs and videos. We offer the free use of these documents under certain conditions
Journalist and Press Contact
Are you a journalist, part of the press or the media? Do you want to get information on our activities, validate your sources in a professional manner, obtain validated photographic material or request an interview?
Next Events
